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Background: Ergot alkaloids are a group of highly bioactive molecules produced by a number of filamentous
fungi. These compounds have been intensely studied for decades, mainly due to their deleterious effects in
contaminated food and feeds, but also for their beneficial pharmaceutical and agricultural applications. Biosynthesis
of ergot alkaloids goes via the common intermediate chanoclavine-I, and studies of the key enzymes, EasE and
EasC, involved in chanoclavine-I formation, have relied on gene complementation in fungi, whereas further
characterization has been hampered by difficulties of poor EasE protein expression. In order to facilitate the study
of ergot alkaloids, and eventually move towards commercial production, the early steps of the biosynthetic pathway
were reconstituted in the unicellular yeast Saccharomyces cerevisiae.
Results: The genomic sequence from an ergot alkaloid producer, Aspergillus japonicus, was used to predict the
protein encoding sequences of the early ergot alkaloid pathway genes. These were cloned and expressed in yeast,
resulting in de novo production of the common intermediate chanoclavine-I. This allowed further characterization
of EasE and EasC, and we were able to demonstrate how the N-terminal ER targeting signal of EasE is crucial for
activity in yeast. A putative, peroxisomal targeting signal found in EasC was shown to be nonessential. Overexpression
of host genes pdi1 or ero1, associated with disulphide bond formation and the ER protein folding machinery, was
shown to increase chanoclavine-I production in yeast. This was also the case when overexpressing host fad1, known
to be involved in co-factor generation.
Conclusions: A thorough understanding of the enzymatic steps involved in ergot alkaloid formation is essential for
commercial production and exploitation of this potent compound class. We show here that EasE and EasC are both
necessary and sufficient for the production of chanoclavine-I in yeast, and we provide important new information
about the involvement of ER and protein folding for proper functional expression of EasE. Moreover, by reconstructing
the chanoclavine-I biosynthetic pathway in yeast we demonstrate the advantage and potential of this host, not only as
a convenient model system, but also as an alternative cell factory for ergot alkaloid production.
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Ergot alkaloids (EA) belong to a diverse group of natural
compounds with a range of biological activities that have
important applications in medicine and agriculture [1-3].
Some of these compounds have a notorious neurological
effect on humans, possibly due to the structural similar-
ity of these compounds to neurotransmitters like sero-
tonin and dopamine [4]. EAs are produced by a variety
of plant associated fungi, mainly of the genera Claviceps
and Aspergillus. The production of ergot alkaloids has
been linked to biosynthetic gene clusters found in sev-
eral species, first in Claviceps purpurea [5] and later in
Aspergillus fumigatus [6,7], Neotyphodium lolii [8], and
others (see [3] for review).
The ergot alkaloids can be divided into three classes,
clavines, ergoamides, and ergopeptines, depending on the
substitutions found on the basic ergoline scaffold. The
biosynthetic pathways leading to various ergot alkaloids
have been partially elucidated, and the early steps leading
to the common biosynthetic intermediate chanoclavine al-
dehyde are identical. After biosynthesis of chanoclavine al-
dehyde the biosynthetic intermediates diverge (Figure 1).
Hence, in C. purpurea the pathway continues via agrocla-
vine to ergotamine and in A. fumigatus via festuclavine to
the fumigaclavines [3].
The first step of the common pathway is the electro-
philic aromatic addition of dimethylallyl-pyrophosphate
(DMAPP) to the 4 position of tryptophan to form
dimethylallyl-tryptophan (DMAT). The reaction is cata-
lysed by a prenyl transferase, DmaW (fgaPT2 in A. fumiga-
tus) [6,9]. The second step, the methylation of DMAT to
form N-methyl-4-dimethylallyltryptophan (Me-DMAT), is
catalysed by the methyltransferase EasF (fgaMT in A. fumi-
gatus) [10].
While the biosynthesis of Me-DMAT is well under-
stood, the mechanistic basis behind the conversion of
Me-DMAT to chanoclavine-I is less clear. The conver-
sion of Me-DMAT to chanoclavine-I was investigated by
gene disruption and complementation studies in C.
pupurea and A. fumigatus: Lorenz and co-workers [11]
used a mutated C. purpurea strain P1 to show that dele-











Figure 1 Biosynthetic pathway to chanoclavine-I and chanoclavine al
dimethylallylpyrophosphate (DMAPP, not shown), via dimethylallyltryptophan
and chanoclavine aldehyde. The aldehyde is considered to be the branch
typically via intermediates like agroclavine and festuclavine.chanoclavine-I and any downstream products. Instead
an accumulation of Me-DMAT was seen, indicating a
block in the pathway after this intermediate. Alkaloid
biosynthesis could be restored by expressing a GFP fu-
sion construct of the easE_Cp gene. Analogously, Goetz
and co-workers [12] disrupted the easC_Af gene in A.
fumigatus, and also observed accumulation of Me-
DMAT and the absence of downstream products. Fur-
thermore, a similar pattern was observed when easE_Af
was disrupted, in concordance with the C. purpurea re-
sults (above). In both of the easE and easC deletion
strains, the alkaloid pathway could be restored by re-
introduction of the corresponding wild type allele. Most
recently Ryan and co-workers [13] transferred part of
the A. fumigatus EA cluster, comprising the four genes
dmaW, easF, easC, and easE, into A. nidulans, a fungus
known as a non-producer of any EA. This partial cluster
conferred the ability to produce chanoclavine-I, further
suggesting that EasE and EasC are sufficient for the con-
version from Me-DMAT. However, the involvement of
enzymes from cryptic EA clusters in A. nidulans cannot
be excluded [14].
Interestingly, EasC_Af contains a C-terminal amino
acid motif (SRL), which is a classic type 1 peroxisomal
targeting signal (PTS1) [15]. Inspection of related pub-
lished sequences reveals that similar PTS1 signals are
found in many EasC homologues from Aspergillus spp.,
but not from Claviceps spp. EasE_Af, on the other hand,
appears to have an N-terminal signal peptide for the
secretory pathway, as previously suggested [12]. The se-
quence has the typical core of hydrophobic amino acids
within the first 15–30 residues, and a signal peptide is
predicted by the SignalP model [16]. However, the impli-
cation of these localisation signals remains unclear, par-
ticularly in light of the apparent co-operation between
EasC and EasE. The EasC proteins have similarity to
peroxisomal catalases [6,7,17]. EasC_Af (the easC_Af
gene product) was purified after expression in E. coli,
and in vitro catalase activity of EasC_Af was shown
using H2O2 as substrate [12]. However, when the en-
zyme was incubated with Me-DMAT, no new product









dehyde. Ergot alkaloids are synthesized from tryptophan and
(DMAT), N-methyl-4-dimethylallyltryptophan (Me-DMAT), chanoclavine-I,
point in the biosynthetic pathways of different ergot alkaloids,
Table 1 Genes used in this study



















Gene names are followed by a two-letter code to indicate species of origin: Aj:
A. japonicus; Af: A. fumigatus; Cp: C. purpurea; Sc: S. cerevisiae. All genes were
synthesized with yeast codon optimization, except for pdi1_Sc, ero1_Sc, and
fad1_Sc, which were prepared by PCR on yeast genomic DNA. Synthesis and
PCR primer design was based on the named sources to give proteins of the
indicated length.
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ever, in all cases, incubation of EasE with Me-DMAT, or
of EasE with Me-DMAT and EasC, failed to produce any
new product. Therefore, biochemical studies to under-
stand the transformation of Me-DMAT to chanoclavine-
I have not been possible.
As an alternative approach to gain information about
the early EA pathway we undertook the reconstitution
of the chanoclavine-I pathway in yeast (S. cerevisiae).
Yeast is the work horse of eukaryotic gene expression
and is easily amenable to genetic manipulation [18,19].
Heterologous genes and proteins are generally well
expressed, and yeast has a long history of use for indus-
trial production of a variety of products [20,21]. We re-
port here the successful engineering of yeast for de novo
production of chanoclavine-I, overcoming the previ-
ously reported difficulties of expressing EasE. Further,
we provide new insight into the roles of EasC and EasE
in the intriguing biochemical conversion from Me-
DMAT into chanoclavine-I, the key step in the early
ergot alkaloid pathway.
Results
Prediction of dmaW coding sequences
An ergot alkaloid gene cluster was recently identified in
A. japonicus [22], one of several fungal species currently
being investigated for their capacity to produce mole-
cules of potential commercial importance [23-25]. A.
japonicus was previously reported to produce cyclocla-
vine [26], an EA of the clavine group, and the genome
sequence of the cluster displays high homology to EA
clusters of Claviceps spp. and Aspergillus spp. This clus-
ter therefore provided an interesting alternative for
studying the chanoclavine-I pathway. The putative cod-
ing sequences (CDS) of dmaW, easF, easC, and easE
were predicted, using free online gene prediction soft-
ware and by alignment to homologues in the GenBank
database (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Ana-
lysis of the dmaW sequence in the A. japonicus genome
revealed two different CDS predictions: one prediction
was for a single open reading frame of 1602 bps, corre-
sponding to a 534 amino acid protein, whereas another
prediction, with the same translation start codon, was
for two exons of 1287 bps and 150 bps separated by an
85 bps intron, corresponding to a 479 amino acid pro-
tein. Both of these predictions were slightly longer than
similar DmaW enzymes found in the GenBank database,
where the lengths of DmaW homologues were in the
range of 435–465 amino acids. Moreover, a multiple
protein alignment in GenBank, using either of the two
A. japonicus DmaW predictions as query, showed a lack
of homology beyond approx. 428 amino acids, i.e. be-
yond the predicted first exon. A somewhat similar situ-
ation was seen for the two entries of A. fumigatusDmaW (Additional file 1: Figure S1). Hence, we decided
to test, not only the two predictions encoding 534 amino
acids (dmaW_Aj1) and 479 amino acids (dmaW_Aj2),
but also a shorter version encoding 429 amino acids
(dmaW_Aj3), corresponding to the predicted first exon.
For easF, representing the next step in the pathway, we
tested the homologues easF_Af and easF_Aj, from A.
fumigatus and A. japonicus, respectively.
Me-DMAT production in yeast
To analyse the biosynthesis of chanoclavine-I we first
constructed a yeast strain designed to produce the
chanoclavine-I precursor Me-DMAT. For this, plasmids
were constructed with synthetic, yeast codon optimized
genes corresponding to each of the three dmaW predic-
tions described above, as well as the dmaW_Cp [Gen-
Bank:AJ011963] and dmaW_Af [GenBank:XM_751048]
(Table 1). All genes were tested by co-expression with a
codon optimized easF_Aj gene. The easF_Aj gene was
cloned in pRS315-C/A, and each dmaW gene was
cloned in the pRS316-C/A, allowing expression from the
yeast Cup1 promoter. Combinations of easF_Aj and
each of the dmaW genes were then introduced in yeast
and expressed by inducing the Cup1 promoter. After
72 h of growth at 30°C, the culture supernatants were
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tio (m/z) of DMAT (m/z = 273.159 +/− 0.01) and Me-
DMAT (m/z = 287.175 +/− 0.01) were extracted from
the total ion chromatograms. The area under the corre-
sponding peaks was calculated and compared, indicating
production of both DMAT and Me-DMAT in the strains
expressing dmaW_Aj2, dmaW_Aj3, and dmaW_Cp, but
essentially no production with dmaW_Aj1 or dmaW_Af
(Figure 2). We suspect that dmaW_Aj1 is likely to be an
incorrect CDS prediction. We also noted that, compared
to the homologue used in a previous study [6], dmaW_Af
has a 24 bp deletion and speculate that the sequence
of dmaW_Af may also be an incorrect prediction.
(Additional file 1: Figure S1). Inspection of the total
ion current chromatogram revealed the appearance of
several additional minor peaks in strains accumulating
the putative DMAT and Me-DMAT. These were not
analysed further but we speculate that they could be
the result of non-enzymatic conversions due to low pH in
the culture medium in the late stationary phase (pH < 4
after 72 hours). Alternatively, they could be shunt prod-
ucts resulting from the activity of yeast metabolic en-
zymes. In any case, the apparent accumulation of DMAT
suggested a relatively poor activity of the methyl transfer-
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Figure 2 Activity of different DmaW and EasF enzymes. Relative
production of DMAT (black bars) and Me-DMAT (grey bars) were
analysed in strains co-expressing EasF_Aj in combination with Dma-
W_Aj1 (A), DmaW_Aj2 (B), DmaW_Aj3 (C), DmaW_Af (D), or DmaW_Cp
(E). Expression of DmaW_Aj1 and DmaW_Af resulted in only small
amounts of compounds compared to the other three DmaW
homologues. Similarly, DmaW_Aj2 was co-expressed with the two
homologues EasF_Aj (G) or EasF_Af (H) and relative DMAT and
Me-DMAT amounts were measured. The EasF_Af resulted in more
than double the amount of Me-DMAT compared to EasF_Aj. The
control strain (F) carried an empty plasmid with no DmaW expression.
The vertical axis shows arbitrary units based on area under the
HPLC peak.the A. fumigatus homologue EasF_Af in comparison to
EasF_Aj. Again, the combination of DmaW_Aj2 and Eas-
F_Aj resulted in accumulation of DMAT (Figure 2,G)
although the relative levels of DMAT and Me-DMAT
showed some variation compared to the previous ex-
periment (Figure 2,B). This could be due to some in vivo
instability of the compounds, as indicated by the shunt
product formation mentioned above, but since it was
not the focus of this work it was not investigated fur-
ther. More importantly, when combining DmaW_Aj2
with the A. fumigatus homologue EasF_Af it appeared
that much more of the produced DMAT was converted
to Me-DMAT (Figure 2,H). Hence, for further studies
the combination of dmaW_Aj2 and easF_Af, which
showed the highest production of Me-DMAT, was inte-
grated into the yeast genome. The new strain was used
to purify Me-DMAT, and the compound was analysed
by 1NMR to confirm the compound identity (Additional
file 1: Figure S2a).Chanoclavine-I production in yeast
Having established the production of Me-DMAT in yeast,
we next addressed the conversion of this compound into
chanoclavine-I. Preliminary results in our laboratory had
shown poor expression of a C-terminal GFP-fusion con-
struct of EasE_Aj, which is consistent with the reported
difficulties of purifying the corresponding enzyme,
EasE_Af, from A. fumigatus [12]. Therefore, in this study,
we tested several easE homologues from A. japonicus, A.
fumigatus, as well as from C. purpurea. To investigate the
hypothesis that EasC and EasE are both required for this
conversion [12,13] we expressed easC_Aj, in combination
with each of the three different easE homologues, in the
background of the Me-DMAT producing yeast (see
above). Each easE homologue was cloned into pRS313-G/
C, and easC_Aj into pRS315-P/A. When combining eas-
C_Aj and easE_Aj we saw the appearance of a new com-
pound with a retention time of 4.3 min, which had the
expected m/z of chanoclavine-I (m/z = 257.165 +/− 0.01).
The compound co-eluted with a compound of identical
mass found in an A. japonicusmycelium extract (Figure 3).
The compound at 4.3 min was purified, and the iden-
tity was confirmed by 1H NMR to be chanoclavine-I
(Additional file 1: Figure S2b). Chanoclavine-I was not
detected in strains expressing easC_Aj in combination with
either easE_Af or easE_Cp, indicating that the A. fumigatus
and C. purpurea homologues used in this study may not
produce functional enzymes in yeast. In strains expressing
only an easE or an easC homologue no chanoclavine-I was
detected, supporting the hypothesis that both EasE and
EasC are required for its biosynthesis. The combination
of easC_Aj and easE_Aj was integrated into the genome






Figure 3 Production of chanoclavine-I enabled by EasE from A.
japonicus. Yeast strains co-expressing DmaW_Aj2, EasF_Af, and
EasC_Aj in combination with one of three different homologues,
EasE_Aj (A), EasE_Af (B), or EasE_Cp (C), were analysed by UPLC-TOF
for chanoclavine-I production. Only the strain co-expressing EasE_Aj
produced chanoclavine-I, whereas no chanoclavine-I was detected
in strains expressing either EasE_Af or EasE_Cp. Retention time and
m/z of (A) corresponded to a chanoclavine-I reference extracted














































Figure 4 Roles of EasE signal peptide, and EasC tripeptide ARL.
Relative production of Me-DMAT (left panel) and chanoclavine-I
(right panel) was analysed, of a Me-DMAT producing strain, co-
expressing EasC and EasE proteins with different localization signals.
Wild type EasE_Aj was co-expressed in combination with either wt
EasC_Aj (A) or EasC_Aj -PTS1which has no PTS1 (B). Removal of the
PTS1 tripeptide ARL resulted in a slight increase of Me-DMAT and
chanoclavine-I. However, when an N-terminally truncated EasE_Aj –
N sig. was co-expressed with either wt EasC_Aj (C) or EasC_Aj -PTS1
(D), production of chanoclavine-I was essentially abolished. The loss
of function, due to the N-terminal truncation of EasE_Aj, resulted
in increased accumulation of the precursor Me-DMAT (C and D
compared to A and B). The vertical axes show arbitrary units based
on areas under the HPLC peaks.
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which was again characterized by 1H NMR.Peroxisomal targeting signal is not needed in yeast
As noted by Goetz and co-workers [12] EasC_Af has a
classical PTS1 peroxisomal targeting sequence, the tri-
peptide SRL, at its carboxy-terminal end similar to PTS1
signals commonly found in yeast [15]. One such putative
signal, ARL, is also present in the A. japonicus EasC_Aj
sequence, as well as in other homologues within the As-
pergillus genus. However, in the Claviceps genus no ob-
vious PTS1 signal is found and the C. purpurea EasC
enzyme instead has a C-terminal IVE tri-peptide, which
has no resemblance to the PTS1 consensus sequence.
Assuming the EA enzymes from these fungi have similar
function, and therefore localization, this is somewhat
puzzling and we therefore wondered if the PTS1 of As-
pergilli is important for function. Hence, we prepared an
EasC-Aj version in which the ARL triplet was deleted. A
set of strains were prepared expressing the integrated dma-
W_Aj2 and easF_Af, together with easE_Aj (in pRS313-
G/C) and either the new easC-Aj -PTS1 version (in
pRS315-P/A) or the original full length easC_Aj (in
pRS315-P/A). To our surprise we saw no major difference
in the ability to produce Me-DMAT and chanoclavine-I.
In fact, the version without the putative PTS1 sequence
resulted in slightly higher concentrations of Me-DMAT
and chanoclavine-I (Figure 4).N-terminal signal is crucial for EasE function
A common feature observed for EasE enzymes is a high
number of hydrophobic amino acids at the N-terminal
end, which is typically associated with signal peptides for
the secretory pathway. Analysis of the amino acid se-
quence of EasE_Aj, using the online SignalP server [16],
confirmed this notion by predicting a signal peptide. A
putative cleavage site in EasE_Aj was predicted after pos.
29, i.e. between A and V. We used this information to
prepare a truncated version of the enzyme, which lacked
the N-terminal sequence, and expressed the corresponding
gene from the pRS313-G/C plasmid, in the Me-DMAT
producing strain, together with easC_Aj (in pRS315-P/A).
The N-truncation seriously impaired the functional expres-
sion of EasE_Aj, and essentially no chanoclavine-I was de-
tected using this enzyme. Instead, accumulation of the
precursor compound Me-DMAT was observed (Figure 4).
To further evaluate the function of the putative signal
peptide we prepared a version of EasE_Aj, in which we
replaced the N-terminal 31 amino acids (predicted signal
peptide including the cleavage site) with the known signal
peptide from the native yeast Pdi1 protein. DNA se-
quences were fused to encode the N-terminal 24 amino
acids from Pdi1, which includes the cleavage site, followed
by the EasE_Aj peptide from pos. 32 (Additional file 1:
Table S2). The fusion protein was tested as described for
the truncated version. When expression was compared to
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I production level was observed, indicating that the Pdi1
signal peptide provided functionality to the enzyme
(Figure 5). This was taken as an indication that for
proper function the EasE needs to enter the secretory
pathway. It is not clear why the yields were lower when
the Pdi1 sequence was used but possibly the cleavage
site of the EasE_Aj could have been wrongly predicted
and proper cleavage thus affected. Translocation across
the ER membrane is a complex matter [27], but presum-
ably a lack of cleavage would cause proteins to getting
stuck in the membrane, and/or to being rapidly de-
graded, but this was not investigated. Testing alternative
fusions of EasE_Aj to the Pdi1 signal, or fusions to other
known signal peptides, might also shed more light on
the function and requirements of the N-terminal signal
sequence of EasE_Aj.
Pdi1 or Ero1 overexpression improves the activity of EasE
in yeast
We speculated that the importance of the N-terminal se-




















Figure 5 Signal peptide from Pdi1 partially restores EasE
function. Concentration (mg/l) of chanoclavine-I, was measured in
the growth medium, of a strain expressing DmaW_Aj2, EasF_Af,
and EasC_Aj after co-expression of different versions of EasE.
Expression of the wt EasE_Aj (A) resulted in production of 0.75
mg/l chanoclavine-I, whereas expression of a modified version (B),
comprising the N-terminal signal peptide from Pdi1, resulted in
production of approximately half of this amount. Complete deletion
of the N-terminal sequence (C) abolished the function of EasE_Aj,
and essentially no chanoclavine-I was detected.formation as part of the protein maturation process,
which would happen during ER associated translation.
EasE_Aj has a total of 9 cysteines which could poten-
tially form disulphide bridges, and the majority of these
cysteines are highly conserved among EasE enzymes
(Additional file 1: Figure S3). For a preliminary evaluation
of the importance of these cysteines we mutated the first
seven of these individually, replacing them with alanine.
All of these mutations resulted in complete loss of func-
tion (data not shown). The native yeast enzymes Pdi1 and
Ero1 are known to have a function in the formation of di-
sulphide bonds in ER (see e.g. [28] for review). Hence, a
pair of chanoclavine-I producing strains were prepared in
which we over-expressed one of the two genes, either pdi1
or ero1, to test whether this would have any impact on the
production of chanoclavine-I. Over-expression of pdi1
(in pRS313-G/C) resulted in an approx. 50% increase in
chanoclavine-I production, whereas ero1 over-expression
(in pRS313-C/A) caused an almost 3 fold increase
(Figure 6), supporting a possible involvement of disulphide
bond formation in proper EasE folding. However, all
chanoclavine-I producing strains also accumulated sub-
stantial amounts of Me-DMAT, indicating continued limi-



















Figure 6 Effects of host engineering on chanoclavine-I
production. Concentration (mg/l) of chanoclavine-I, was measured
in the growth medium, of a chanoclavine-I producing control strain
(A) and after over-expression of Pdi1 (B), Ero1(C), or Fad1 (D).
Over-expression of these native yeast genes all resulted in an increased
production of chanoclavine-I, relative to the control. All strains expressed
the integrated, heterologous pathway to chanoclavine-I.
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EasE has previously been described as a flavin adenine
dinucleotide (FAD) dependent reductase or dehydrogen-
ase, and in support of this the structural similarity to the
class of berberine bridge enzymes (BBE) has previously
been pointed out [11]. In plants the BBE enzyme is in-
volved in alkaloid biosynthesis, and it has been associ-
ated with transport from ER to the vacuole [29]. BBE
was shown to bi-covalently bind a flavin co-factor [30]
and the binding site, involving a histidine and a cysteine,
seems to be conserved in EasE_Aj and other EasE en-
zymes (Additional file 1: Figure S4). With ample evi-
dence that EasE is FAD dependent, we speculated
whether an increased supply of this co-factor would dir-
ectly improve the activity of EasE. An attempt to increase
the supply via the growth medium showed no effect on
chanoclavine-I production (data not shown), so instead
we cloned the native yeast fad1 gene, which encodes the
enzyme responsible for synthesis of FAD from flavin
mono nucleotide (FMN). Over-expression of this gene, in
a strain harbouring the chanoclavine-I pathway, led to a
2.5 fold increase in chanoclavine-I production (Figure 6)
which we interpreted as an effect of improved co-factor
supply.
Discussion
Heterologous expression in yeast of the four enzymes
DmaW_Aj2, EasF_Af, EasC_Aj, and EasE_Aj led to pro-
duction of chanoclavine-I, demonstrating that yeast is a
suitable host for producing ergot alkaloids. This work
also confirms, in accordance with previous published
studies, that EasC and EasE are solely responsible for
the conversion of Me-DMAT to chanoclavine-I without
the involvement of other EA enzymes. Secondary metab-
olism in S. cerevisiae is quite limited and it seems un-
likely that any yeast enzyme would be involved in the
highly specialized metabolic process of ergot alkaloid
biosynthesis. The production of chanoclavine-I depended
on the expression of EasE from A. japonicus, whereas EasE
from A. fumigatus or C. purpurea were not active when
expressed in yeast. We speculate that the predicted coding
regions of easE_Af and easE_Cp, along with dmaW_Aj3,
could be incorrect (see below, and Additional file 1:
Figure S3 and S5). Certainly, the prediction of intron and
exon sequences in filamentous fungi is still a challenge.
Our results support the notion that EasE and EasC co-
operate to produce chanoclavine-I, but it is still not clear
how or where this process occurs. Knockout experiments
of easC and easE in Aspergillus fumigatus [12], along with
the data presented here, indicate that the catalytic activities
of two classes of enzymes, a catalase encoded by easC and
a FAD-dependent oxidoreductase encoded by easE, are
both required to convert Me-DMAT to chanoclavine-I.
Deletion mutants of easC and easE accumulate Me-DMAT, which suggests, though does not prove, that these
two enzymes act in a coordinated fashion. It is also pos-
sible that the ergot alkaloid pathway requires dispropor-
tionation of H2O2, and that the function of EasC is to
remove H2O2 derived from the oxidative activities of EasE.
More extensive biochemical experiments with active EasE
enzyme would be able to shed further light on these
questions.
As shown here the putative PTS1 signal of EasC_Aj
was not essential for function, and it is possible that even
with the PTS1 signal the natural cellular distribution in-
volves multiple locations, as seen for some native yeast
proteins [31,32]. The N-terminal signal of the EasE, on
the other hand, was clearly crucial for function, and the
fact that a native yeast signal peptide from Pdi1 partially
restored function indicates that EasE contains a genuine
ER targeting signal. This would suggest that folding and
disulphide bond formation in the ER is needed for proper
maturation of EasE and that it passes through the
secretory pathway before, possibly, joining up with
EasC. Cellular localization studies might help elucidate
this puzzle, just as further progress toward obtaining
in vitro activity of EasC and EasE should allow us to ex-
plore the interdependence of these two enzymes on one
another.
The case for oxidative folding of EasE in ER is supported
by the observed increase in chanoclavine-I production
after over-expression of either of the two key enzymes in
the yeast disulphide bridge formation machinery. Ero1 is a
sulfhydryl oxidase responsible for generating disulphide
bonds that are passed on to Pdi1, which in turn oxidizes
the cysteines of newly translated proteins [28,33,34]. The
EasE family contains several highly conserved cysteines
that would be available for oxidation, although one cyst-
eine is likely to be involved in binding the FAD co-factor.
Interestingly, a multiple sequence alignment of the
EasE_Aj and its closest homologues showed some unex-
pected dissimilarity regarding EasE_Af and EasE_Cp
(Additional file 1: Figure S5). The first approx. 130 amino
acids of EasE_Af showed no similarity to the consensus
sequence, whereas EasE_Cp seemed to be completely
lacking the N-terminal domain. An earlier prediction of
EasE_Cp [11] suggested a 483 amino acid peptide de-
rived from two exons. A newer GenBank entry [Gen-
Bank:JN186799], however, predicts a third exon at the
5-end and encodes a 595 amino acid protein, including
a signal peptide as predicted by the SignalP model [16].
The study [11] reported complementation of an
easE_Cp gene knock-out after integration of a PCR frag-
ment comprising the same easE gene including its native
promoter region. We speculate that this PCR fragment
may by chance have included the first exon, allowing cor-
rect splicing and, hence, full complementation. Comple-
mentation by re-integration into the easE locus was
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firmed by Southern hybridization. A similar approach was
used for studying the easE gene in A. fumigatus [12]. The
native easE gene was first disrupted, which abolished
function, and the WT sequence was then re-integrated
along with 1445 bps 5’-flanking sequence. The inclusion
of upstream sequence would allow the fungus to splice
the gene correctly, and any divergence between the ma-
ture mRNA and the predicted CDS of easE_Af would not
have been detected. We analysed the genomic region of
A. fumigatus chromosome II using an online intron pre-
diction model, which suggested an 1809 bps easE_Af
coding sequence, encoding a protein of 602 amino acids
including a putative N-terminal signal peptide. This
newly predicted protein shows very high sequence simi-
larity to other EasE proteins in the multiple alignment
(Additional file 1: Figure S3). We synthesized a yeast
codon optimized version of this predicted easE_Af, and
tested its ability to support chanoclavine-I formation. In a
strain co-expressing dmaW_Cp, easF_Af, and easC_Aj,
the expression of either easE_Af or easE_Aj resulted in
similar levels of chanoclavine-I production (data not
shown). This would indicate that, at least in this case, the
EasC and EasE enzymes from different fungi are capable
of working together. However, further studies are needed
to confirm the results, and to investigate the nature of co-
operation between EasC and EasE.
Conclusion
We show here that EasC and EasE are responsible for
the conversion of Me-DMAT to chanoclavine-I in yeast.
Although the activity of these enzymes appears to be
linked, the cellular localization of the enzymatic reaction
is unclear. The N-terminal peptide sequence of EasE was
identified as a signal for the secretory pathway, and a
role for ER-associated folding was supported by a benefi-
cial effect of overexpressing host enzymes involved in
protein disulphide bond formation.
Surprisingly, a putative C-terminal PTS1 in EasC ap-
peared to be non-essential, at least in a yeast host back-
ground, and the cellular localization of EasC cannot be
predicted. Further studies will be needed to address ques-
tions regarding cellular localization of the enzymes, and
much work is still pending towards a full understanding
of the biochemical reactions involved. Nonetheless, the
knowledge we have obtained in this study should enable
further elucidation of these reactions.
Importantly, we also demonstrate that the biosynthetic
pathway for chanoclavine-I, the central biosynthetic pre-
cursor for all ergot alkaloids, can be transferred to the
industrially important host, S. cerevisae. This discovery
will greatly facilitate further genetic and metabolic engin-
eering of the ergot alkaloid pathway, which will potentially
have a broad range of pharmaceutical and agrochemicalapplications. Our results therefore provide an entry
point on the road to commercial scale production of
known or novel ergot alkaloids with important indus-
trial applications.
Methods
DNA and protein sequence analysis
Computer-aided sequence analysis was done using Vector
NTI 9.1.0 software (Invitrogen Corp. 2004) and the free on-
line software FGENESH (http://linux1.softberry.com/berry.
phtml), GENSCAN (http://genes.mit.edu/GENSCAN.html),
and the NCBI server (http://www.ncbi.nlm.nih.gov). Signal
peptides were predicted using the SignalP 4.0 tool [16].
Preparation and cloning of genes in yeast expression
vectors
Synthetic genes, codon optimized for expression in yeast,
were manufactured by DNA2.0 Inc., Menlo Park, CA,
USA or GeneArt AG, Regensburg, Germany. All se-
quences were derived from A. japonicus, A. fumigatus, or
C. purpurea. The genes encode the amino acid sequences,
plus a translation stop codon, of DmaW_Af [GenBank:
XP_756141], DmaW_Cp [GenBank:CAB39314], EasF_Af
[GenBank:XP756143], EasC_Af [GenBank:XP756140],
EasE_Af [GenBank:XP756142], and EasE_Cp [GenBank:
CAB39328]. The sequences dmaW_Aj1, easF_Aj, easC_Aj,
and easE_Aj were predicted, based on the genomic DNA
sequence of the cycloclavine gene cluster of A. japonicus
[22]. All genes were synthesized with the DNA sequence
AAGCTTAAA, containing a HindIII restriction recogni-
tion site, at the 5’-end and with a SacII recognition site at
the 3’-end (CCGCGG), and these sites were used for clon-
ing. All PCR primers used for sub-cloning contained these
sequences. Standard PCR conditions were used according
to manufacturer’s recommendations (BioRad iProof High
Fidelity DNA polymerase, Cat. #172-5302).
Gene dmaW_Aj3 was prepared by PCR using dma-
W_Aj1 as template, and dmaW_Aj2 was prepared by se-
quential extension PCR, using dmaW_Aj3 as template,
thus adding the second exon in two steps (Additional
file 1: Table S1). The easC_Aj version without C-terminal
PTS1 signal was prepared by PCR amplification of the
coding sequence (CDS) without the 9 bps before the stop
codon. The EasE_Aj N-terminal truncation (EasE_Aj -N
sig.) was done by PCR, amplifying the corresponding CDS
without the first 87 bps. The forward PCR primer inserted
an alternative ATG translation start site. The fusion of an
N-terminal signal peptide from Pdi1 to the N-truncated
EasE_Aj was done by overlapping extension PCR, fusing
the two amplicons to encode Pdi1-EasE_Aj (Additional
file 1: Table S2). The CDS of the native yeast genes pdi1
[GenBank:D00842], ero1 [GenBank:NM_001182493], and
fad1 [GenBank:NM_001180104] were amplified from gen-
omic DNA by PCR.
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vectors based on pRS313, pRS315, and pRS316 [35].
These vectors had been provided with a new multi-
cloning site (MCS) linker, inserted between the two PvuII
sites. The basic design of the MCS was SrfI-AscI-BglII-
HindIII-SfiI(a)-SfiI(b)-SacII-SphI-AscI-SrfI [36]. The linker
allowed cloning of promoter sequences into BglII and
HindIII, and terminators into SacII and SphI restriction
sites to create yeast expression cassettes. Promoters and
terminators were amplified from yeast genomic DNA by
PCR (Additional file 1: Table S3) for preparing three ex-
pression cassettes containing 1) a GPD1 promoter and a
CYC1 terminator (G/C), 2) a PGK1 promoter and an
ADH2 terminator (P/A), and 3) a CUP1 promoter and an
ADH1 terminator (C/A). The new expression vectors were
named pRS31X-G/C, pRS31X-P/A, and pRS31X-C/A,
where X designates 3, 5, or 6. All genes used in this study
(Table 1) were cloned into expression cassettes of these
vectors.
Construction and integration of yeast gene expression
cassettes
Constructs for integration were prepared for the integra-
tion sites YORWΔ22 and YPRCΔ15 [37], and cloned in
unique EcoRI and HindIII sites of a pUC19 vector back-
bone. The homologous regions were constructed from
two PCR fragments, which were then combined by over-
lapping extension PCR. The PCR primers introduced the
restriction sites AscI and NotI between the two original
fragments, and SbfI sites at the outer ends. The KanMX
cassette, flanked by loxP sites, was excised from pUG6
[38] and inserted into NotI. Two expression cassettes
(described above) were inserted into the AscI site. The
first cassette was amplified by PCR, changing one AscI
site to a MluI. After cloning this fragment, the second
cassette was inserted into the single regenerated AscI
site. The entire construct was released by SbfI and used
for integration. This approach was used to first integrate
dmaW_Aj2 (G/C cassette) and easF_Af (P/A cassette)
into the yeast genome at the YORWΔ22 site. After exci-
sion of the KanMX marker [38], the easC_Aj (G/C cas-
sette) and easE_Aj (P/A) cassette were integrated into the
YPRCΔ15 site. Yeast transformations were done using the
LiAc method [39].
Yeast strain and culture conditions
Chanoclavine-I production was achieved in several S.
cerevisiae strain backgrounds, including S288C, W303,
and others (not shown). The strain used to prepare the
results in this report had the genotype MATα, his3Δ1,
leu2Δ0, lys2Δ0, ura3Δ0. Engineered yeast strains were
grown in standard SC broth with 2% glucose, minus leu-
cine and histidine (ForMedium, Hunstanton, U.K.). When
appropriate, CuSO4 was added to a final concentration of300 μM for induction of gene expression. Cultures for
analysis were started from re-streaked, single colonies.
These were grown overnight in standard SC broth, and
then diluted to an optical density, at 600 nm, of 0.1 to
start the main culture. Main cultures were grown at 30°C
with constant shaking at 150 rpm, 5 cm amplitude, for
72 hours in 250 ml shake flasks containing 25 ml medium.
Final optical density was measured at 600 nm, typically
reaching 12–14, although small variations were seen be-
tween individual experiments.
Analytical procedures
For analysis yeast cultures were spun down for 10 min
at 1000 × g. The pellet and the supernatant were sepa-
rated. Without further purification, 5 μl of supernatant
were injected in a UPLC-TOF (Waters Acquity™ Ultra
Performance LC, Waters, Milford, Mass., USA) coupled
to a micrOTOF-Q II (Bruker Daltonik GmbH, Bremen,
Germany). Stationary phase was an Acquity UPLC®
Bridged Ethyl Hybrid (BEH) C18, 1.7 μm, 2.1 × 100 mm
column. Liquid chromatography used mobile phases of
H2O + 0.1% formic acid (A), and acetonitrile + 0.1% for-
mic acid (B), in a linear gradient of 1% to 100% B in 5
min. The column was washed for 1 min in 100% B, and
then equilibrated for 1.5 min in 1% B. Detection of com-
pounds was done by a photo diode array using the fol-
lowing parameters: λ range 210 nm to 500 nm.
Resolution 1.2 nm. Sampling rate 5 points/s. ELSD pa-
rameters: gain 50, gas pressure 40 psi, nebulizer mode
heating, power level 80%, drift tube 80°C. TOF parame-
ters Source: End Plate Offset −500 V. Capillary −4500 V.
Nebulizer 1.6 bar. Dry gas 8.0 l/min. Dry temperature
180°C. TOF parameters Scan mode: MS Scan. Mass range
from 80 to 1000 m/z. Quantification of chanoclavine-I
was based on in-house, purified reference compound.
Preparative procedures
For compound purifications yeast cultures were spun
down for 10 min at 1000 × g. The supernatant was ad-
justed to pH = 10 with 10 M NaOH and extracted by li-
quid/liquid extraction with an equal volume of ethyl
acetate. The crude extract was dried under vacuum and
reconstituted with dimethyl sulfoxide (DMSO) to a con-
centration of 100 mg/ml and then purified on a preparative
HPLC system (Waters, Milford, Mass, USA). Stationary
phase was an XBridge™ preparative C18, 5 μm, 19 ×
250 mm column. Liquid chromatography used mobile
phases of H2O + 0.1% trifluoroacetic acid (A), and
acetonitrile + 0.1% trifluoroacetic acid (B), in a linear
gradient of 1% to 30% B in 40 min. The column was
washed for 5 min in 100% B, and then equilibrated for
5 min in 1% B. Fractions were collected every 2 min and
analyzed as above. Fractions containing the purified an-
alyte were pooled and dried under vacuum.
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